Follow us for updates
© 2020 reportr.world
Read the Story →

Sinovac Vaccines from China Arriving in February, Total Order 25 Million

Total 25 million doses by year-end.
by Arianne Merez
6 days ago
Photo/s: Shutterstock
Shares

(UPDATE) The Philippines in February will receive its initial supply of COVID-19 vaccines from China, Malacañang said Monday, paving the way for the start of immunization efforts.

An initial 50,000 doses of vaccines from China's Sinovac will arrive next month, part of the secured 25 million doses of the drug, Presidential Spokesperson Harry Roque said.

"Dadating na ang bakuna sa Pilipinas sa susunod na buwan," Roque said in a Palace press briefing.

"Huwag naman kayo masyado mag-celebrate diyan dahil ang paunang darating po ay 50,000 doses lang ng vaccine galing sa Sinovac. Pero at least, magsisimula na rin po tayo," he added.

ALSO READ:

Philippines Could Receive COVID-19 Vaccines by February: DOH

COVID-19 immunization czar Carlito Galvez Jr. had previously said that Manila's initial supply of vaccines could come from China, where the rapidly spreading disease was first reported in late 2019.

Earlier,  Health Usec. Rosario Vergeire said at least two brands of COVID-19 vaccines could be delivered to the Philippines by next month but refused to disclose the labels.

Continue reading below ↓

So far, the national government has signed two vaccine deals--one with  British pharmaceutical firm AstraZeneca for 2.6 million doses of its vaccine developed with Oxford University, and another with US drug maker Novavax for the purchase of 30 million doses of its COVID-19 vaccine called Covovax.

ALSO READ:

Philippines Secures 30 Million Novavax Vaccine Doses

Up to 70 Million Filipinos to Get COVID-19 Vaccine in 2021: Roadmap

COVID Vaccine Prices, Efficacy, Safety Compared

The Philippines is eyeing to start its mass immunization program by late March, global supply permitting. It hopes to secure 148 million doses this year from seven companies -- enough for around 70% of its population. 

Latest Headlines
Read Next
Recent News
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to reportr.world newsletter, you agree to our Terms of Service and Privacy Policy.